PHAXIAM Therapeutics S.A. (PHXM.PA)

EUR 0.58

(-3.01%)

Total Assets Summary of PHAXIAM Therapeutics S.A.

  • PHAXIAM Therapeutics S.A.'s latest annual total assets in 2023 was 51.3 Million EUR , up 12.0% from previous year.
  • PHAXIAM Therapeutics S.A.'s latest quarterly total assets in 2024 Q2 was 39.11 Million EUR , down 0.0% from previous quarter.
  • PHAXIAM Therapeutics S.A. reported annual total assets of 45.81 Million EUR in 2022, down -31.39% from previous year.
  • PHAXIAM Therapeutics S.A. reported annual total assets of 66.76 Million EUR in 2021, down -16.96% from previous year.
  • PHAXIAM Therapeutics S.A. reported quarterly total assets of 39.11 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • PHAXIAM Therapeutics S.A. reported quarterly total assets of 51.3 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of PHAXIAM Therapeutics S.A. (2023 - 2016)

Historical Annual Total Assets of PHAXIAM Therapeutics S.A. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 51.3 Million EUR 12.0%
2022 45.81 Million EUR -31.39%
2021 66.76 Million EUR -16.96%
2020 80.4 Million EUR -32.18%
2019 118.54 Million EUR -29.37%
2018 167.84 Million EUR -14.04%
2017 195.26 Million EUR 334.23%
2016 44.96 Million EUR 0.0%

Peer Total Assets Comparison of PHAXIAM Therapeutics S.A.

Name Total Assets Total Assets Difference
Nicox S.A. 52.98 Million EUR 3.158%
European Medical Solutions 43.75 Million EUR -17.252%
FERMENTALG 50.24 Million EUR -2.116%
argenx SE 4.11 Billion EUR 98.752%
BioSenic S.A. 9.55 Million EUR -436.74%
Celyad Oncology SA 16.28 Million EUR -215.115%
Hyloris Pharmaceuticals SA 47.68 Million EUR -7.605%
Onward Medical N.V. 43.62 Million EUR -17.598%
Oxurion NV 6.55 Million EUR -683.313%
Financière de Tubize SA 1.92 Billion EUR 97.328%
UCB SA 15.53 Billion EUR 99.67%